Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Miranda Morton.

Newcastle AuthorsTitleYearFull text
Dr Arthur Pratt
Dr Stefan Siebert
Mike Cole
Dr Deborah Stocken
Amy Cranston
et al.
Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trial2021
Dr Stefan Siebert
Dr Arthur Pratt
Dr Deborah Stocken
Dr Miranda Morton
Amy Cranston
et al.
Targeting the rheumatoid arthritis synovial fibroblast via cyclin dependent kinase inhibition: An early phase trial2020
Dr Emma Clark
Dr Miranda Morton
Shriya Sharma
Dr Holly Fisher
Denise Howel
et al.
Prostate cancer androgen receptor splice variant 7 biomarker study - A multicentre randomised feasibility trial of biomarker-guided personalised treatment in patients with advanced prostate cancer (the VARIANT trial) study protocol2019
Dr Ashleigh Herriott
Dr Miranda Morton
Professor Nicola Curtin
Phase I, dose-escalation, two-part trial of the PARP inhibitor talazoparib in patients with advanced germline BRCA1/2 mutations and selected sporadic cancers2017
Iaroslava Kos
Dr Miranda Morton
Alessandra da Silva Dantas
Professor Janet Quinn
Mechanisms underlying the delayed activation of the Cap1 transcription factor in Candida albicans following combinatorial oxidative and cationic stress important for phagocytic potency2016
Dr Alastair Greystoke
Dr Linda Hogarth
Dr Miranda Morton
Liam Bolt
Dianne Turner
et al.
The introduction of the Cancer Research UK Stratified Medicine Programme 2 (CRUK SMP2) in North East England; lessons learned and experience gained2016
Fiona Middleton
Dr Miranda Morton
Dr Claire Elstob
Dr Sarah Fordham
Dr Ashleigh Herriott
et al.
Common cancer-associated imbalances in the DNA damage response confer sensitivity to single agent ATR inhibition2015
Dr Ashleigh Herriott
Dr Susan Tudhope
Gesa Junge
Natalie Rodrigues
Dr Miranda Morton
et al.
PARP1 expression, activity and ex vivo sensitivity to the PARP inhibitor, talazoparib (BMN 673), in Chronic Lymphocytic Leukaemia2015
Dr Miranda Morton
Dr Ian Forrest
Becci Sharrock
Maria Lane
Dr Angelika Kaufmann
et al.
Assessing the function of homologous recombination DNA repair in malignant pleural effusion (MPE) samples2014
Dr Miranda Morton
Professor Janet Quinn
Mechanisms Underlying the Exquisite Sensitivity of Candida albicans to Combinatorial Cationic and Oxidative Stress That Enhances the Potent Fungicidal Activity of Phagocytes2014
James Murray
Huw Thomas
Philip Berry
Suzanne Kyle
Dr Miranda Morton
et al.
Tumour cell retention of rucaparib, sustained PARP inhibition and efficacy of weekly as well as daily schedules2014
Dr Miranda Morton
Professor Nicola Curtin
Microsatellite instability induced mutations in DNA repair genes CtIP and MRE11 confer hypersensitivity to poly (ADP-ribose) polymerase inhibitors in myeloid malignancies2013
Dr Miranda Morton
Alessandra da Silva Dantas
Dr Elizabeth Veal
Professor Brian Morgan
Professor Janet Quinn
et al.
Ybp1 and Gpx3 Signaling in Candida albicans Govern Hydrogen Peroxide-Induced Oxidation of the Cap1 Transcription Factor and Macrophage Escape2013
Dr Miranda Morton
Professor Janet Quinn
Impact of combinatorial stresses upon Candida albicans2012
Dr Miranda Morton
James Murray
Professor Nicola Curtin
Stability of PARP Inhibition by BMN 673 in Human PBMCs (and Leukaemic Cell Cultures)2012
Alessandra da Silva Dantas
Dr Miranda Morton
Professor Brian Morgan
Professor Janet Quinn
Thioredoxin regulates multiple hydrogen peroxide-induced signaling pathways in Candida albicans2010
Jill Cheetham
Alessandra da Silva Dantas
Dr Miranda Morton
Dr Catherine Bruce
Professor Janet Quinn
et al.
A single MAPKKK regulates the Hog1 MAPK pathway in the pathogenic fungus Candida albicans2007